• Your Selections:

Refine Results

date

Topics

Content Type

Tags

The U.S. Response to Coronavirus: Summary of the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020

The Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020, which was passed with near unanimous support in both the House and Senate, was signed into law by the President on March 6, 2020. The bill provides $8.3 billion in emergency funding for federal agencies to respond to the coronavirus outbreak. This summary provides details on funding specified in the bill.

Distributing a COVID-19 Vaccine Across the U.S. – A Look at Key Issues

This brief examines key policy challenges and issues related to distributing a COVID-19 vaccine in the U.S., including funding, supply and logistics, federal, state, and local authorities, insurance coverage, addressing racial and ethnic disparities, and communication and trust.

The Current Ebola Outbreak and the U.S. Role: An Explainer

An outbreak of Ebola is currently ongoing in the Democratic Republic of Congo (DRC), now the second largest Ebola epidemic ever recorded. This Issue Brief gives an overview of the current situation, explains the U.S. role in responding to the outbreak, and answers key questions about the broader global response.

Vaccine Coverage, Pricing, and Reimbursement in the U.S.

The brief provides an overview of how vaccines are reimbursed and covered across government programs and different types of health insurance in the United States. It coverage regulations specific to COVID-19 vaccine(s).

Private Health Coverage of COVID-19: Key Facts and Issues

New federal legislation will require most private health plans to cover testing for the coronavirus with no cost sharing. Some states have adopted similar requirements for insurers they regulate, and many private insurance companies will voluntarily expand coverage for testing. However, some private coverage will not be subject to these requirements. To date, fewer changes have been adopted or considered with respect to treatment for complications from the disease. This brief reviews current coverage standards for private health plans and how these may change in response to the COVID-19 pandemic.

States Are Getting Ready to Distribute COVID-19 Vaccines. What Do Their Plans Tell Us So Far?

This brief summarizes the information contained in the all available draft COVID-19 vaccination plans submitted by states to the CDC, focusing in particular in critical areas such as identifying critical/priority populations, identifying and recruiting providers to administer vaccines, the completeness of state-level vaccine data collection and reporting systems, and communication plans. States report widely varying levels of progress.

The U.S. and Gavi, the Vaccine Alliance

This fact sheet examines the Gavi, the Vaccine Alliance (also known as Gavi), an independent, public-private partnership and multilateral funding mechanism that aims to increase access to immunization in poor countries, and explores the role the U.S. government plays in supporting the partnership.

Drew Altman: Pharmacies, Not the Military, Will Handle COVID-19 Vaccinations

President Trump has conjured up the image of a top general and the military delivering the coronavirus vaccine drawing on their vast logistical experience. In his latest Axios column, Drew Altman explains why vaccine realities will dictate that it’s much more likely to be at your local Walgreens or CVS pharmacy.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.